Atopic Dermatitis - The Dermatology Digest

AD Pipeline Watch: First Patient Dosed in Part B of Phase 2 APEX Trial of Apogee’s APG777 in Moderate-to-Severe AD

February 3, 2025

Research Sheds Light on the Itch Paradox

January 31, 2025

Maui Derm News: Kids With Severe AD Catch Up on Growth With Dupilumab

January 21, 2025

What is TSW? New Study Seeks Clarity on Topical Steroid Withdrawal

January 14, 2025

AD Pipeline Update: Target Enrollment Complete in Phase 2b Trial of Nectar’s Rezpegaldesleukin in AD

January 13, 2025

AD Pipeline Watch: CAGE Bio Initiates Phase 2b Trial for CGB-500, a Topical JAK Inhibitor for Moderate to Severe AD

January 10, 2025

Advertisement

Latest Issue

Latest Supplements

Advertisement

Digital Edition Archive